Clinical Site

Glendale, California 91206

1 studies enrolling now · 7 studies all time

What they study most

Age-related Macular Degeneration, BRVO - Branch Retinal Vein Occlusion, Bipolar Depression, Diabetic Macular Edema, Generalized Anxiety Disorder, Healthy Volunteers (Part 1), Major Depressive Disorder, Major Depressive Disorder (Part 2), Neovascular Age-related Macular Degeneration, Wet Macular Degeneration

Studies at this site

• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) — Completed
• A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders — Completed
• An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
• Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder — Completed